BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell will be one of 30 companies to present their latest innovations at CES Unveiled New York on November 10 . CES Unveiled is produced by the Consumer Electronics Association to provide a sneak peek at the year's most
BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) and Prism Health Care Services, Inc. , an affiliate of The Alden Network, today announced an agreement under which Prism will be the exclusive distributor of Quell ® wearable pain relief technology in Illinois and Wisconsin for patients in
Approximately 4,500 Quell ® Devices Shipped, Up 73% Compared to Q2 2015 DPNCheck ® Shipments at Three Year High of Nearly 40,000 Biosensors Revenue Up 44% to $2.1 Million Compared to Q3 2014 WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO) announced today that it plans to issue its 2015 third quarter financial results before the opening of the market on October 22, 2015 . The Company will host a conference call at 8:00 a.m., Eastern Time on October 22, 2015 to
BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell has been selected for the fifth annual Innovators Challenge that takes place during the Partners Healthcare's Connected Health Symposium on October 29 . The Innovators Challenge was established to showcase
BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Hammacher Schlemmer will feature Quell ® Wearable Pain Relief Technology in their upcoming catalog. "Hammacher Schlemmer has a 167-year history of offering the latest and most innovative products," said Frank McGillin ,
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), reported today that it has engaged CorProminence, LLC for investor relations services. CorProminence is a New York -based investor relations and strategic advisory firm with a business focus on small to mid-size companies.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO) reported today the Quell ® app is now available in Google Play. Quell is an over-the-counter wearable pain relief device that utilizes proprietary non-invasive neurostimulation technology to provide relief from chronic pain.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO), reported that Quell was featured on ABC's Good Morning America on September 17 in a segment titled " Erase Your Pain ". Good Morning America is the #1 morning show in the US, reaching nearly 5 million households each week.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported purchases during August 2015 of the company's common stock by its Chief Executive Officer, Dr. Shai N. Gozani and Chief Financial Officer, Thomas T. Higgins . Details of these transactions may be found on the U.S.
